Novo Nordisk A/S is a Danish pharmaceutical company headquartered in Bagsværd, Denmark, known for developing and manufacturing treatments for diabetes, obesity, and other serious chronic conditions. Their publicly stated purpose is to drive better health outcomes by providing accessible medicines and advancing science, technology and partnerships in disease-areas where the need is greatest. The company emphasizes sustainability and ethical business practices, with a commitment to its patients, healthcare professionals, and broader societal impact. On their website they also highlight their pipeline of new therapies and provide detailed investor, sustainability and career information.